Tag Archive for: the psychedelic investor
https://psychedelicspotlight.com/wp-content/uploads/2021/11/Compass_Pathways_Clinical_Trial_Psilocybin_PTSD_Psychedelic_Spotlight.jpg 875 1310 James Hallifax https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png James Hallifax2021-11-04 21:35:152021-11-04 21:35:15Why We’re Excited About Compass Pathways’ New Clinical Trial Treating PTSD with Psilocybin
Compass Pathways (Nasdaq: CMPS) has announced the launch of a brand new psychedelic clinical trial, using psilocybin (the active ingredient in magic mushrooms) to treat PTSD, and there are multiple reasons to be excited about it. The Phase-2…
https://psychedelicspotlight.com/wp-content/uploads/2021/10/Why_Psychedelic_Stocks_Have_Crashed_Last_Three_Months_Psychedelic_Spotlight.jpg 875 1310 James Hallifax https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png James Hallifax2021-10-13 22:19:562021-10-13 22:32:30Why Psychedelic Stocks Have Crashed in the Last 3 Months
Our resident psychedelic investor explains why psychedelic stocks are plummeting, and why patience can pay off big time.